Physician profile
Peter Sabbagh
NPI 1295046746
$9,194.31
in general payments reported to CMS, 2019-2025
36 companies · $920 in 2025
The $920 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2021: $112 · 2022: $640 · 2023: $1,078 · 2024: $5,880 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,079 · Food and Beverage: $2,717 · Travel and Lodging: $1,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,078.99 |
| Food and Beverage | $2,716.87 |
| Travel and Lodging | $1,082.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,099.43 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $872.75 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Philips North America LLC | $292.11 | 2019-2024 | (8874) Incourage |
| Actelion Pharmaceuticals US, INC. | $279.32 | 2019-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $277.35 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $243.88 | 2019-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.38 | 2019-2023 | |
| Harmony Biosciences LLC | $183.69 | 2022-2025 | |
| Inspire Medical Systems, INC. | $178.44 | 2024 | Inspire |
| Amgen INC. | $171.08 | 2024-2025 | Tezspire, Tavneos |
| Ethicon INC. | $145.89 | 2023 | Monarch Platform |
| Mallinckrodt Enterprises LLC | $136.21 | 2019 | |
| Resmed Corp | $134.65 | 2023-2025 | |
| Insmed, INC. | $110.71 | 2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $110.31 | 2024-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $101.72 | 2024 | |
| La Jolla Pharmaceutical Company | $99.99 | 2023 | Giapreza |
| Verona Pharma, INC. | $74.28 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $51.57 | 2023-2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Itamar Medical INC | $48.82 | 2025 | Watchpatone |
| Mylan Specialty L.P. | $47.34 | 2023-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $40.93 | 2023-2025 | |
| Baxter Healthcare | $30.20 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $28.94 | 2024-2025 | Glassia |
| Grifols USA, LLC | $28.18 | 2022 | |
| Circassia INC. | $27.42 | 2019 | |
| Ani Pharmaceuticals, INC. | $25.03 | 2024 | Purified Cortrophin Gel |
| Abbvie INC. | $22.67 | 2022 | |
| Lilly USA, LLC | $18.45 | 2025 | Zepbound |
| Inogen, INC. | $17.29 | 2023 | Inogen |
| Advanced Respiratory, INC | $17.23 | 2019 | |
| Covis Pharma Gmbh | $15.85 | 2022 | |
| Zoll Respicardia, INC. | $14.01 | 2025 | Remede System |
| Sandoz INC. | $13.74 | 2023 | Treprostinil |
| Genentech USA, INC. | $13.23 | 2021 | |
| Electromed, INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Sabbagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.